The White House Is Pushing Puberty Blockers for ‘Trans Kids.’ It’s Relying on a Problematic Study.


Assessment: The Biden administration’s endorsement could pave the way for broader acceptance of the use of puberty blockers and hormone therapy in children …

The Biden administration promoted the use of puberty blockers for transgender children by citing a study from an LGBT group funded in part by a manufacturer of the controversial drugs used in gender reassignment.

In statements commemorating “Transgender Day of Visibility,” the White House and Department of Health and Human Services cited research from the Trevor Project to support the use of puberty blockers, hormone therapy, and sex-reassignment procedures in children seeking to change genders. Two of the Trevor Project’s donors, AbbVie and Allergan, make drugs and medical products used in the medical gender transition process. The charitable foundations of both companies gave at least $50,000 to the Trevor Project, according to a review of tax documents and the Trevor Project’s website. The Trevor Project did not disclose the funding in its research.

It would be better for him if a millstone were hung around his neck, and he were thrown into the sea, than that he should offend one of these little ones.” Luke 17:2 

(Jeopardy champion Amy Schneider speaks at White house on Transgender visibility day)

The Biden administration’s support for “gender-affirming” care, the progressive buzzword for gender transitions, comes as conservatives push to stop the prescription of hormones and puberty blockers to children. Texas governor Greg Abbott (R.) has called on the state’s child welfare service to open abuse investigations into parents who give puberty blockers and hormones to children.

Texas attorney general Ken Paxton (R.) subpoenaed AbbVie and drug maker Endo Pharmaceuticals, claiming both companies improperly promote the use of puberty blockers in transgender children.

Read More @ Free Beacon HERE